"Comparing Salvage Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer"

PHASE3RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

October 30, 2027

Study Completion Date

October 30, 2027

Conditions
Prostate Cancer
Interventions
COMBINATION_PRODUCT

Individualised therapy

"Group I - No uptake: treated with conventional SRT against the prostate bed. Group II -Uptake only in the prostate bed: will receive intensity modulated RT (IMRT) including Volumetric Modulated Arc Therapy (VMAT) for prostate bed with simultaneous-integrated boost (SIB) to the PET positive uptake in the prostate bed.~Group III - Uptake in the prostate bed and involvement of regional lymph nodes in the pelvis: will be treated as Group II plus VMAT for the pelvic lymph nodes with SIB to the PET positive lymph nodes or pelvic lymph nodes salvage lymph node dissection (SLND).~Group IV - Uptake in regional lymph nodes only: will be treated with VMAT for the pelvic lymph nodes with SIB to the PET positive lymph nodes or pelvic lymph nodes SLND.~Group V - Uptake in extra-pelvic lymph nodes or bone metastasis: systemic treatment instead of surgery or radiation. Local treatment with surgery or radiation is acceptable if curative intention."

RADIATION

Standard salvage therapy

Standard salvage radiotherapy

Trial Locations (5)

413 45

RECRUITING

Sahlgrenska University Hospital, Gothenburg

118 83

NOT_YET_RECRUITING

Södersjukhuset, Stockholm

171 76

RECRUITING

Karolinska University Hospital, Stockholm

901 85

NOT_YET_RECRUITING

Norrland's University Hospital, Umeå

701 85

NOT_YET_RECRUITING

Örebro University Hospital, Örebro

All Listed Sponsors
lead

Stefan Carlsson

OTHER